These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Management of hypertrophic cardiomyopathy in children. Seggewiss H; Rigopoulos A Paediatr Drugs; 2003; 5(10):663-72. PubMed ID: 14510624 [TBL] [Abstract][Full Text] [Related]
9. Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators. Maron BJ; Casey SA; Olivotto I; Sherrid MV; Semsarian C; Autore C; Ahmed A; Boriani G; Francia P; Winters SL; Giudici M; Koulova A; Garberich R; Rowin EJ; Sears SF; Maron MS; Spirito P Circ Arrhythm Electrophysiol; 2018 Apr; 11(4):e005820. PubMed ID: 29625970 [TBL] [Abstract][Full Text] [Related]
10. Management of hypertrophic cardiomyopathy. Enriquez AD; Goldman ME Ann Glob Health; 2014; 80(1):35-45. PubMed ID: 24751563 [TBL] [Abstract][Full Text] [Related]
11. [Hypertrophic cardiomyopathy in 2013]. Giannakopoulos G; Frangos C Rev Med Suisse; 2013 Mar; 9(376):502, 504-7. PubMed ID: 23534110 [TBL] [Abstract][Full Text] [Related]
12. The T-peak-to-T-end interval: a novel ECG marker for ventricular arrhythmia and appropriate ICD therapy in patients with hypertrophic cardiomyopathy. Dinshaw L; Münch J; Dickow J; Lezius S; Willems S; Hoffmann BA; Patten M Clin Res Cardiol; 2018 Feb; 107(2):130-137. PubMed ID: 28965260 [TBL] [Abstract][Full Text] [Related]
13. Sudden death as a presenting symptom of hypertrophic cardiomyopathy: treatment with an implantable cardioverter defibrillator. Talard P; Lévy S; Bonal J; Paganelli F; Bouchiat C; Cellarier G; Dussarat GV Pacing Clin Electrophysiol; 1996 Aug; 19(8):1264-7. PubMed ID: 8865227 [TBL] [Abstract][Full Text] [Related]
14. Hypertrophic Cardiomyopathy, Athlete's Heart, or Both: A Case of Hypertrophic Cardiomyopathy Regression. Kebed KY; Bos JM; Anavekar NS; Mulvagh SL; Ackerman MJ; Ommen SR Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003312. PubMed ID: 26162782 [No Abstract] [Full Text] [Related]
15. Sudden death and hypertrophic cardiomyopathy: a review. Ly HQ; Greiss I; Talakic M; Guerra PG; Macle L; Thibault B; Dubuc M; Roy D Can J Cardiol; 2005 Apr; 21(5):441-8. PubMed ID: 15861263 [TBL] [Abstract][Full Text] [Related]
16. Hypertrophic cardiomyopathy: management issues in the new millennium. Thaman R; Firoozi S; Hamid MS; McKenna WJ Curr Cardiol Rep; 2002 May; 4(3):226-32. PubMed ID: 11960592 [TBL] [Abstract][Full Text] [Related]
17. Low occurrence of ventricular arrhythmias after alcohol septal ablation in high-risk patients with hypertrophic obstructive cardiomyopathy. Rigopoulos AG; Daci S; Pfeiffer B; Papadopoulou K; Neugebauer A; Seggewiss H Clin Res Cardiol; 2016 Nov; 105(11):953-961. PubMed ID: 27270758 [TBL] [Abstract][Full Text] [Related]
18. Utilization and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Hypertrophic Cardiomyopathy. Goldstein SA; Kennedy KF; Friedman DJ; Al-Khatib SM; Wang A J Am Heart Assoc; 2023 Aug; 12(16):e029293. PubMed ID: 37586066 [TBL] [Abstract][Full Text] [Related]
19. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Ommen SR; Mital S; Burke MA; Day SM; Deswal A; Elliott P; Evanovich LL; Hung J; Joglar JA; Kantor P; Kimmelstiel C; Kittleson M; Link MS; Maron MS; Martinez MW; Miyake CY; Schaff HV; Semsarian C; Sorajja P J Am Coll Cardiol; 2020 Dec; 76(25):e159-e240. PubMed ID: 33229116 [No Abstract] [Full Text] [Related]
20. Risk assessment and prevention of sudden cardiac death in hypertrophic cardiomyopathy. Slade AK; Camm AJ Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():37-49. PubMed ID: 8734163 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]